ResMed to sell software business MatrixCare for $490 million - Reuters
ResMed to sell software business MatrixCare for $490 million Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT2NvNGJFSGdUVm5fODh6ZjhUTXFOeWhXLTkxWnVaTjJ0WC1HU3hraGJNcER0SDh0T184Z2U3RzdZQ0cxaFFiVDMza2h4Z091SHdBa015N044bThMb2JrSW1hcXgtY1RleGlvd0V6c0NzNFZEZ183LUhjaGlYZWRXbVJSa09Ba0lFZXdBNDJYakd0a1d5dUpkX0kxdGZYZWxXVkNCVi1VaEQ?oc=5" target="_blank">ResMed to sell software business MatrixCare for $490 million</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PMApplied Digital's revenue soars, loss widens on growing AI investments - Reuters
Applied Digital's revenue soars, loss widens on growing AI investments Reuters
October 7, 2026 at 09:23 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMDental firm vVardis reveals revenue surge in US IPO filing - Reuters
Dental firm vVardis reveals revenue surge in US IPO filing Reuters
October 9, 2026 at 07:31 PMEXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say - Reuters
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say Reuters
October 8, 2026 at 09:37 PMBecton Dickinson pledges $19 billion US investment in deal with government - Reuters
Becton Dickinson pledges $19 billion US investment in deal with government Reuters
October 6, 2026 at 03:06 PM